2-(Methylthio)-8-nitro-6-(trifluoromethyl)-4H-benzo[e][1,3]thiazin-4-one, 96%, 250mg

(2S,3S)-METHYL 3-HYDROXYPYRROLIDINE-2-CARBOXYLATE HCL, 95.0%, 500mg

Tert-butyl4-(aminomethyl)-2-azabicyclo[2.1.1]hexane-2-carboxylate, 97%, 100mg

4-(2-Bromoethyl)benzene-1,2-diol, 97%, 250mg

6-chloro-3-(hydroxyimino)-2,3-dihydro-1H-indol-2-one, 97%, 100mg

3-Chloro-4-hydroxybenzonitrile, 99.0%, 5g

2-(Dimethoxyphosphoryl)acetic acid, 97%, 1g

DI-TERT-BUTYL 6-METHYLENE-1,4-DIAZEPANE-1,4-DICARBOXYLATE, 95.0%, 1g

(S)-Ethyl 6-(5-bromofuran-2-yl)-7,9-dimethyl-8,10-dioxo-11-phenyl-7,8,9,10-tetrahydro-6H-benzo[b]pyrimido[4',5':3,4]pyrrolo[1,2-d][1,4]oxazine-2-carboxylate, 98%, 25mg

3-Fluoro-4-(trifluoromethoxy)phenol, 95.0%, 5g

2-Ethoxy-1,3,5-trifluorobenzene, 98%, 10g

Colonne capillaire GC ROTI®Cap-5 MS Ultra, 60 m, 0,20 mm, 0,35 µm, 1 pièce(s)

(3,3-Dimethoxycyclobutane-1,1-diyl)dimethanol, 95.0%, 100mg